EP3397280 - PESTIVIRUS MARKER VACCINE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 12.02.2021 Database last updated on 16.11.2024 | |
Former | Examination is in progress Status updated on 09.04.2019 | ||
Former | Request for examination was made Status updated on 05.10.2018 | ||
Former | The international publication has been made Status updated on 07.07.2017 | ||
Former | unknown Status updated on 24.01.2017 | Most recent event Tooltip | 12.02.2021 | Application deemed to be withdrawn | published on 17.03.2021 [2021/11] | Applicant(s) | For all designated states Intervet International B.V. Wim de Körverstraat 35 5831 AN Boxmeer / NL | [2018/45] | Inventor(s) | 01 /
REIMANN, Ilona Suedufer 10 17493 Greifswald-Insel Riems / DE | 02 /
KÖNIG, Patricia Südufer 10 17493 Greifswald-Insel Riems / DE | 03 /
BEER, Martin Suedufer 10 17493 Greifswald-Insel Riems / DE | [2018/45] | Representative(s) | Intervet International B.V. Hertford Road Hoddesdon, Hertfordshire EN11 9BU / GB | [2018/45] | Application number, filing date | 16826054.5 | 23.12.2016 | [2018/45] | WO2016EP82537 | Priority number, date | EP20150203202 | 30.12.2015 Original published format: EP 15203202 | [2018/45] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017114778 | Date: | 06.07.2017 | Language: | EN | [2017/27] | Type: | A1 Application with search report | No.: | EP3397280 | Date: | 07.11.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.07.2017 takes the place of the publication of the European patent application. | [2018/45] | Search report(s) | International search report - published on: | EP | 06.07.2017 | Classification | IPC: | A61K39/12, C07K14/005, C12N7/04 | [2018/45] | CPC: |
A61K39/12 (EP,US);
A61P31/12 (EP);
A61P31/14 (EP);
A61P37/04 (EP);
C07K14/005 (EP,US);
C12N7/04 (EP,US);
A61K2039/5252 (EP,US);
A61K2039/5254 (US);
A61K2039/55555 (EP,US);
A61K2039/575 (US);
C07K2319/00 (EP,US);
C12N2770/24321 (EP,US);
C12N2770/24322 (EP,US);
C12N2770/24334 (EP,US);
C12N2770/24362 (EP,US);
C12N2770/24371 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/45] | Title | German: | PESTIVIRUSMARKERIMPFSTOFF | [2018/45] | English: | PESTIVIRUS MARKER VACCINE | [2018/45] | French: | VACCIN MARQUEUR DE PESTIVIRUS | [2018/45] | Entry into regional phase | 30.07.2018 | National basic fee paid | 30.07.2018 | Designation fee(s) paid | 30.07.2018 | Examination fee paid | Examination procedure | 01.06.2018 | Amendment by applicant (claims and/or description) | 30.07.2018 | Examination requested [2018/45] | 30.07.2018 | Date on which the examining division has become responsible | 12.04.2019 | Despatch of a communication from the examining division (Time limit: M04) | 12.08.2019 | Reply to a communication from the examining division | 06.04.2020 | Despatch of a communication from the examining division (Time limit: M06) | 17.10.2020 | Application deemed to be withdrawn, date of legal effect [2021/11] | 06.11.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2021/11] | Fees paid | Renewal fee | 10.12.2018 | Renewal fee patent year 03 | 10.12.2019 | Renewal fee patent year 04 | 09.12.2020 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]EP1174506 (STICHTING DIENST LANDBOUWKUNDI [NL]) [A] 1-21 * paragraph [0027] * * abstract ** figure 1 *; | [A]WO2013027149 (AH USA 42 LLC [US], et al) [A] 1-21 * the whole document *; | [AD]WO2014033149 (INTERVET INT BV [NL], et al) [AD] 1-21 * abstract * * page 5, line 15 - line 20 * * page 15, line 4 - line 35 *; | [I] - MEYER DENISE ET AL, "New insights into the antigenic structure of the glycoprotein Ernsof classical swine fever virus by epitope mapping", VIROLOGY, (20120804), vol. 433, no. 1, doi:10.1016/J.VIROL.2012.06.029, ISSN 0042-6822, pages 45 - 54, XP028938148 [I] 20 * abstract * * page 46, column l, paragraph l - column r, paragraph 2 * * figure 5 * DOI: http://dx.doi.org/10.1016/j.virol.2012.06.029 | [AD] - YUGANG LUO ET AL, "Construction of chimeric bovine viral diarrhea viruses containing glycoprotein Erns of heterologous pestiviruses and evaluation of the chimeras as potential marker vaccines against BVDV", VACCINE, (20120601), vol. 30, no. 26, doi:10.1016/j.vaccine.2012.04.016, ISSN 0264-410X, pages 3843 - 3848, XP055044173 [AD] 1-21 * the whole document * DOI: http://dx.doi.org/10.1016/j.vaccine.2012.04.016 | [AD] - MARIA RICHTER ET AL, "Complementation studies with the novel Bungowannah virus provide new insights in the compatibility of pestivirus proteins", VIROLOGY, vol. 418, no. 2, doi:10.1016/J.VIROL.2011.07.014, ISSN 0042-6822, (20110722), pages 113 - 122, (20110727), XP028277426 [AD] 1-21 * the whole document * DOI: http://dx.doi.org/10.1016/j.virol.2011.07.014 | [A] - P.L. EBLÉ ET AL, "Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: Protection and DIVA characteristics", VETERINARY MICROBIOLOGY, (20130301), vol. 162, no. 2-4, doi:10.1016/j.vetmic.2012.10.030, ISSN 0378-1135, pages 437 - 446, XP055102685 [A] 1-21 * the whole document * DOI: http://dx.doi.org/10.1016/j.vetmic.2012.10.030 |